Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ENDOXAN for Diffuse large b-cell lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 14 adverse event reports in the FDA FAERS database where ENDOXAN was used for Diffuse large b-cell lymphoma.

Most Reported Side Effects for ENDOXAN

Side Effect Reports % Deaths Hosp.
Death 56 13.4% 56 0
No adverse event 37 8.9% 0 0
Maternal exposure before pregnancy 26 6.2% 0 0
Musculoskeletal disorder 25 6.0% 0 0
Toxicity to various agents 24 5.7% 8 0
Disease progression 21 5.0% 6 1
Febrile neutropenia 20 4.8% 0 3
Disease recurrence 19 4.6% 3 0
Pneumonia 15 3.6% 3 1
Acute graft versus host disease 14 3.4% 1 0
Bone marrow failure 11 2.6% 3 3
Drug ineffective 11 2.6% 6 1
Exposure via father 11 2.6% 0 0
Pyrexia 11 2.6% 2 9
Breast cancer recurrent 10 2.4% 0 0

Other Indications for ENDOXAN

Breast cancer stage i (58) Stem cell transplant (49) Neoplasm malignant (37) Lupus nephritis (24) Bone marrow conditioning regimen (23) Chronic lymphocytic leukaemia (23) Breast cancer (21) Plasma cell myeloma (21) B-cell lymphoma (14) Temporal arteritis (12)

Other Drugs Used for Diffuse large b-cell lymphoma

RITUXIMAB (22,275) CYCLOPHOSPHAMIDE (16,598) DOXORUBICIN (15,213) VINCRISTINE (14,922) PREDNISONE (11,266) LENALIDOMIDE (7,858) ETOPOSIDE (4,698) PREDNISOLONE (4,086) CYTARABINE (3,857) DEXAMETHASONE (3,696)

Related Pages

ENDOXAN Full Profile All Diffuse large b-cell lymphoma Drugs ENDOXAN Demographics ENDOXAN Timeline